Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mario Luca Suva, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Mario Suva and Nicolo Riggi.
Connection Strength

1.921
  1. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol. 2007 Sep; 213(1):4-20.
    View in: PubMed
    Score: 0.362
  2. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. 2019 08 08; 178(4):835-849.e21.
    View in: PubMed
    Score: 0.206
  3. IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer. Genes Dev. 2016 11 15; 30(22):2459-2474.
    View in: PubMed
    Score: 0.171
  4. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature. 2016 11 10; 539(7628):309-313.
    View in: PubMed
    Score: 0.171
  5. The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing. Cell Rep. 2016 05 24; 15(8):1634-47.
    View in: PubMed
    Score: 0.165
  6. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell. 2014 Apr 24; 157(3):580-94.
    View in: PubMed
    Score: 0.143
  7. Epigenetic reprogramming in cancer. Science. 2013 Mar 29; 339(6127):1567-70.
    View in: PubMed
    Score: 0.133
  8. Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev. 2012 Sep 01; 26(17):1926-44.
    View in: PubMed
    Score: 0.128
  9. A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma. Cancer Cell. 2012 Jun 12; 21(6):807-21.
    View in: PubMed
    Score: 0.126
  10. Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development. PLoS One. 2011; 6(8):e23592.
    View in: PubMed
    Score: 0.119
  11. Ewing's sarcoma origin: from duel to duality. Expert Rev Anticancer Ther. 2009 Aug; 9(8):1025-30.
    View in: PubMed
    Score: 0.103
  12. Sarcomas: genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations. J Pathol. 2007 Oct; 213(2):117-30.
    View in: PubMed
    Score: 0.091
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.